Scientific evaluation of negative exome sequencing followed by systematic scoring of candidate genes to decipher the genetics of neurodevelopmental disorders

• Published in: bioRxiv
• Main Authors: Buttner, Benjamin, Martin, Sonja, Finck, Anja, Arelin, Maria, Baade-Buttner, Carolin, Bartolomaeus, Tobias, Bauer, Peter, Bertsche, Astrid, Bernhard, Matthias K, Biskup, Saskia, Nataliya Di Donato, Elgizouli, Magdeldin, Ewald, Roland, Heine, Constanze, Hellenbroich, Yorck, Hentschel, Julia, Hoffjan, Sabine, Horn, Susanne, Hornemann, Frauke, Huhle, Dagmar, Kamphausen, Susanne B, Kiess, Wieland, Krey, Ilona, Kuechler, Alma, Liesfeld, Ben, Merkenschlager, Andreas, Mitter, Diana, Muschke, Petra, Pfaffle, Roland, Polster, Tilman, Schanze, Ina, Jan-Ulrich Schlump, Syrbe, Steffen, Wieczorek, Dagmar, Zenker, Martin, Lemke, Johannes R, Diana Le Duc, Platzer, Konrad, Rami Abou Jamra
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 26.03.2019
• Subjects: Neurodevelopmental disorders
• DOI: 10.1101/588517

Background: Deciphering the monogenetic causes of neurodevelopmental disorders (NDD) is an important milestone to offer personalized care. But the plausibility of reported candidate genes in exome studies often remains unclear, which slows down progress in the field. Methods: We performed exome sequencing (ES) in 198 cases of NDD. Cases that remained unresolved (n=135) were re-investigated in a research setting. We established a candidate scoring system (CaSc) based on 12 different parameters reflecting variant and gene attributes as well as current literature to rank and prioritize candidate genes. Results: In this cohort, we identified 158 candidate variants in 148 genes with CaSc ranging from 2 to 11.7. Only considering the top 15% of candidates, 14 genes were already published or funneled into promising validation studies. Conclusions: We promote that in an approach of case by case re-evaluation of primarily negative ES, systematic and standardized scoring of candidate genes can and should be applied. This simple framework enables better comparison, prioritization, and communication of candidate genes within the scientific community. This would represent an enormous benefit if applied to the tens of thousands of negative ES performed in routine diagnostics worldwide and speed up deciphering the monogenetic causes of NDD.